Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis

NCT07646223 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis (UC)
Primary Sclerosing Cholangitis (PSC)
Pediatric Inflammatory Bowel Diseases

Interventions

DRUG: Oral Vancomycin

Sponsor

Tampere University Hospital

Collaborators

[object Object]
[object Object]